| 3 Administration | |||
| E Physiological Systems and Anatomical Regions | |||
| 0 Introduction : Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |||
| Body System / Region | Approach | Substance | Qualifier |
| Character 4 | Character 5 | Character 6 | Character 7 |
| 0 Skin and Mucous Membranes | X External | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| 0 Skin and Mucous Membranes | X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 1 Subcutaneous Tissue | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| 1 Subcutaneous Tissue | 3 Percutaneous | V Hormone | G Insulin J Other Hormone |
| 2 Muscle | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| 2 Muscle | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 3 Peripheral Vein | 0 Open | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 3 Peripheral Vein | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 3 Peripheral Vein | 0 Open | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| 3 Peripheral Vein | 0 Open | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| 3 Peripheral Vein | 0 Open | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| 3 Peripheral Vein | 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 3 Peripheral Vein | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 3 Peripheral Vein | 3 Percutaneous | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| 3 Peripheral Vein | 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| 4 Central Vein | 0 Open | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 4 Central Vein | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 4 Central Vein | 0 Open | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| 4 Central Vein | 0 Open | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| 4 Central Vein | 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 4 Central Vein | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 4 Central Vein | 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| A Bone Marrow | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| F Respiratory Tract | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| F Respiratory Tract | 3 Percutaneous | S Gas | D Nitric Oxide F Other Gas |
| F Respiratory Tract | 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| L Pleural Cavity M Peritoneal Cavity | 0 Open | 5 Adhesion Barrier | Z No Qualifier |
| L Pleural Cavity M Peritoneal Cavity | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| L Pleural Cavity M Peritoneal Cavity | 3 Percutaneous | S Gas | F Other Gas |
| L Pleural Cavity M Peritoneal Cavity | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | G Other Therapeutic Substance | C Other Substance |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | S Gas | F Other Gas |
| R Spinal Canal | 0 Open | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| R Spinal Canal | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| R Spinal Canal | 3 Percutaneous | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| S Epidural Space | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| T Peripheral Nerves and Plexi X Cranial Nerves | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| U Joints | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| U Joints | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| U Joints | 3 Percutaneous | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| V Bones | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| V Bones | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| V Bones | 3 Percutaneous | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| W Lymphatics | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| W Lymphatics | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Y Pericardial Cavity | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 0 Skin and Mucous Membranes | X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Local Anesthetic K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| 0 Skin and Mucous Membranes | X External | G Other Therapeutic Substance | C Other Substance |
| 1 Subcutaneous Tissue | 0 Open | 2 Anti-infective | A Anti-Infective Envelope |
| 1 Subcutaneous Tissue | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| 2 Muscle | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| A Bone Marrow | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| F Respiratory Tract | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| P Female Reproductive | 0 Open | 5 Adhesion Barrier | Z No Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| Q Cranial Cavity and Brain | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| R Spinal Canal | 0 Open | A Stem Cells, Embryonic | Z No Qualifier |
| R Spinal Canal | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| R Spinal Canal | 3 Percutaneous | S Gas | F Other Gas |
| R Spinal Canal | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| S Epidural Space | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| S Epidural Space | 3 Percutaneous | S Gas | F Other Gas |
| S Epidural Space | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| U Joints | 0 Open | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein |
| U Joints | 3 Percutaneous | S Gas | F Other Gas |
| V Bones | 0 Open | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein |
| W Lymphatics | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Y Pericardial Cavity | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Y Pericardial Cavity | 3 Percutaneous | S Gas | F Other Gas |
| Y Pericardial Cavity | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| 1 Subcutaneous Tissue | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective A Anti-Infective Envelope |
| 3 Peripheral Vein | 0 Open | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| 3 Peripheral Vein | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase |
| 3 Peripheral Vein | 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| 4 Central Vein | 0 Open | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| 4 Central Vein | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase |
| 4 Central Vein | 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | S Gas | F Other Gas |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| F Respiratory Tract | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Q Cranial Cavity and Brain | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| U Joints | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Y Pericardial Cavity | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Y Pericardial Cavity | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| 1 Subcutaneous Tissue | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| 2 Muscle | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| S Epidural Space | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic C Regional Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| 3 Peripheral Vein | 0 Open | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| 3 Peripheral Vein | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| 4 Central Vein | 0 Open | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| 4 Central Vein | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| R Spinal Canal | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| S Epidural Space | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| 3 Peripheral Vein | 0 Open | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| 4 Central Vein | 0 Open | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| 4 Central Vein | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | K Other Diagnostic Substance P Platelet Inhibitor | Z No Qualifier |
| F Respiratory Tract | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| T Peripheral Nerves and Plexi X Cranial Nerves | 3 Percutaneous | 3 Anti-inflammatory B Local Anesthetic C Regional Anesthetic T Destructive Agent | Z No Qualifier |
| U Joints | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| V Bones | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| W Lymphatics | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| F Respiratory Tract | 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| F Respiratory Tract | 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | D Nitric Oxide F Other Gas |
| L Pleural Cavity M Peritoneal Cavity | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | Q Fertilized Ovum | 0 Autologous 1 Nonautologous |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| F Respiratory Tract | 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| L Pleural Cavity M Peritoneal Cavity | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| L Pleural Cavity M Peritoneal Cavity | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| F Respiratory Tract | 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic D Inhalation Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| P Female Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance L Sperm N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives R Antiarrhythmic T Destructive Agent | Z No Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| L Pleural Cavity M Peritoneal Cavity | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| R Spinal Canal | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Local Anesthetic C Regional Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |